Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 4/2021

01-04-2021 | Ankylosing Spondylitis | Correspondence

Exploring simplified disease activity indices in Ankylosing Spondylitis in different populations is the need of the hour

Authors: T. G. Sundaram, Latika Gupta

Published in: Rheumatology International | Issue 4/2021

Login to get access

Excerpt

We thank Capelunsik et al. [1] for their comments on our original article, ‘A prospective study of novel disease activity indices for ankylosing spondylitis’ [2]. We commend the work by rheumatology researchers at the Instituto de Rehabilitación Psicofísica (IREP) in Argentina, in developing the Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) [3]. …
Literature
1.
2.
3.
Zamora N, Schneeberger EE, Orozco MC, Cayetti LA, Sommerfleck FA, Citera G (2013) Desarrollo y validación de una versión simplificada del índice de actividad para Espondilitis Anquilosante—SASDAS—utilizando PCR, en una cohorte de pacientes con espondiloartritis axial. Rev Arg Reumatol 24(Supl esp):67
4.
5.
6.
7.
Metadata
Title
Exploring simplified disease activity indices in Ankylosing Spondylitis in different populations is the need of the hour
Authors
T. G. Sundaram
Latika Gupta
Publication date
01-04-2021
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 4/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-021-04805-7

Other articles of this Issue 4/2021

Rheumatology International 4/2021 Go to the issue

Case Based Review

Aortic involvement in relapsing polychondritis: case-based review

Observational Research

‘But you don’t look sick’: a qualitative analysis of the LUPUS UK online forum

Observational Research

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

Observational Research

Perceptions of patients with rheumatoid arthritis about self-assessment of disease activity after watching an educational video: a qualitative pilot study from the AUTO-DAS in Middle Eastern Arab countries project

Case Based Review

COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review

Systematic Review

Association of systemic lupus erythematosus with hearing loss: a systemic review and meta-analysis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits